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Abstract
Purpose In this work, we addressed fully automatic determination of tumor functional uptake from positron emission
tomography (PET) images without relying on other image modalities or additional prior constraints, in the context of
multicenter images with heterogeneous characteristics.
Methods In cervical cancer, an additional challenge is the location of the tumor uptake near or even stuck to the bladder.
PET datasets of 232 patients from five institutions were exploited. To avoid unreliable manual delineations, the ground truth
was generated with a semi-automated approach: a volume containing the tumor and excluding the bladder was first manually
determined, then a well-validated, semi-automated approach relying on the Fuzzy locally Adaptive Bayesian (FLAB)
algorithm was applied to generate the ground truth. Our model built on the U-Net architecture incorporates residual blocks
with concurrent spatial squeeze and excitation modules, as well as learnable non-linear downsampling and upsampling
blocks. Experiments relied on cross-validation (four institutions for training and validation, and the fifth for testing).
Results The model achieved good Dice similarity coefficient (DSC) with little variability across institutions (0.80±0.03),
with higher recall (0.90±0.05) than precision (0.75±0.05) and improved results over the standard U-Net (DSC 0.77±0.05,
recall 0.87±0.02, precision 0.74±0.08). Both vastly outperformed a fixed threshold at 40% of SUVmax (DSC 0.33±0.15,
recall 0.52±0.17, precision 0.30±0.16). In all cases, the model could determine the tumor uptake without including the
bladder. Neither shape priors nor anatomical information was required to achieve efficient training.
Conclusion The proposed method could facilitate the deployment of a fully automated radiomics pipeline in such a
challenging multicenter context.
Keywords Convolutional neural network · PET · Segmentation · Cervical cancer · U-Net
Introduction
Combined positron emission tomography/computed tomog-
raphy (PET/CT) imaging is widely used in clinical practice
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to provide functional information on organs and tissues, as
well as disease abnormalities. Static PET images provide
semi-quantitative information regarding the distribution of a
radiotracer uptake. In oncology, fluorodeoxyglucose (FDG)
PET imaging is routinely relied upon for diagnosis, staging,
treatment planning, and therapy follow-up [20].
In clinical applications, nuclear medicine physicians
carry out qualitative assessments of PET/CT images,
which is typically sufficient for detecting and anatomically
locating lesions. For radiotherapy treatment planning,
radiation oncologists manually draw boundaries on fused
PET/CT images to determine the gross target volume (GTV)
of a tumor, in order to subsequently deliver a specific dose
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to the target. The boundary of the target should be defined as
accurately as possible to maximize the coverage of the target
and minimize the dose delivered to surrounding healthy
tissues and nearby organs-at-risk (OAR).
More quantitative assessment of FDG uptake in PET
images can also be performed. For instance, radiomics anal-
yses [23] aim at extracting clinically relevant measurements
through the calculation of numerous image-derived features
features (e.g., intensity, shape, and textural). Such measures
can subsequently be used to build models predictive of out-
come or for assessing changes in tumors before, during, and
after treatment in order to better evaluate response to ther-
apy [7, 37, 38]. It has been shown in all image modalities
including PET that the choice of the segmentation method in
this step of the radiomics workflow can significantly affect
the extracted features [21, 31, 42, 46, 51]. In addition, it is
recognized that in the absence of fully automated segmen-
tation, this step is a crucial bottleneck and time-consuming
step of any radiomics study, preventing such a process to be
expanded to very large datasets [23]. There is therefore a
need for a delineation method that is not only accurate and
robust, but also fully automated as well.
There are several challenges pertaining to PET image
segmentation [20]. First, PET images suffer from limited
spatial resolution (4–5 mm), comparatively to CT (below
1 mm) due to partial volume effects (PVE) that make
boundaries between adjacent functional regions blurred and
result in underestimated activity in small objects of interest.
Second, signal-to-noise ratio in PET images is inherently
low and affected by a vast array of factors, such as scanner
sensitivity, temporal resolution, acquisition mode, scan
time, quantity and distribution of tracer, applied corrections
(e.g., scatter, attenuation, randoms) and reconstruction
algorithm type (e.g., resolution recovery, time of flight)
and parameters (e.g., number of iterations). All these issues
make things challenging in a multi-center context, i.e., when
analyzing PET images acquired using different systems,
acquisition protocols, and reconstruction settings. Third,
the wide variability in shapes and heterogeneity of lesion
uptakes might reduce the generalization of segmentation
methods to only some specific cases.
An important aspect in medical image segmentation is
that the true boundary of the object of interest (ground
truth) is impossible to determine without a complete
histopathological analysis of an excised tumor, which can
typically be performed only in a small number of cases.
In PET, even with a very robust protocol, this approach
can only provide approximate co-registration between
the histopathology slides and the corresponding 3D PET
slices [20]. One way to overcome this is the use of a
consensus of several manual segmentations by experts as a
surrogate of truth [20]. Unfortunately, manual segmentation
is typically a labor-intensive, time-consuming task with low
reproducibility, due to the high intra- and interobserver
variability [19].
There have been a number of algorithms proposed
for PET image segmentation, accounting at different
degrees for some of the limitations referred to above
[20]. For example, thresholding-based methods, the most
simple image segmentation techniques, work on the
assumption that different tissue types have specific uptake
ranges; therefore, segmentation can be done by comparing
individual voxel intensities with a set of thresholds. More
advanced methods aim at exploiting statistical differences
between uptake regions and surrounding tissues. These
include different clustering and classification methods
trained on a set of features extracted from PET images,
as well as atlas-based [39, 45] and generative models
such as Gaussian mixture models (GMM) [2] and Fuzzy
Locally Adaptive Bayesian (FLAB) model [16]. Numerous
other common image segmentation algorithms have been
evaluated for this task using PET uptake only [20]. For
the vast majority of these published methods, it is usually
assumed that the tumor has been previously isolated in a
volume of interest (VOI), i.e., the input to the algorithm is
not the entire PET image but a sub-volume containing the
object of interest, that is usually manually determined after
visually detecting the tumor uptake in the whole image.
It should be emphasized that numerous approaches tried
to improve PET segmentation by considering both PET
and CT modalities together, assuming an (almost) perfect
correspondence between tumor functional uptake and tumor
anatomical boundaries as determined on CT images using
co-segmentation approaches exploiting co-registered PET
and CT images [9, 14, 34]. This assumption may not
be true as radiotracer uptake and anatomical boundaries
can be uncorrelated. This also makes the method sensitive
to registration issues in PET imaging, especially in body
regions affected by motion [20].
Convolutional neural networks (CNNs) have been
successfully applied to different medical imaging tasks
[35], such as reconstruction [32, 43], denoising [10,
44], segmentaton [13, 40], and classification [6]. Most
segmentation studies rely on U-Net [47] that is arguably
the most popular network for semantic segmentation, and
focus on anatomical modalities such as magnetic resonance
imaging (MRI) [8, 40] and CT [41, 48]. The limited number
of papers dedicated to PET segmentation usually assume a
correspondence between functional and anatomical regions
in combined PET/CT or PET/MRI imaging [12, 26, 52–
54]. The ground truth is usually obtained through manual
delineation performed on multimodal images (e.g., training
a network to reproduce delineations performed by radiation
oncologist that perform this manually on fused PET/CT
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images). Guo et al. [13] included PET imaging within
a CNN-based multimodal image segmentation framework
using PET, MR (T1 and T2), and CT images of a
publicly available soft tissue sarcoma dataset of 50 patients.
Gross tumor volumes were manually annotated in all
four imaging modalities. Different fusion networks were
used for feature-, classifier-, and decision-level fusion,
demonstrating improved performance at a feature level
fusion [13].
Considerably less attention has been dedicated to pro-
cessing PET images as a stand-alone modality. Moreover,
a majority of studies have used only datasets with small
cohorts of patients from one or two centers and manual
delineation as a surrogate of truth. Under these circum-
stances, some previously published results might be less
generalizable due to high heterogeneity of PET images
caused, for instance, by scanner type, reconstruction algo-
rithm, and applied post-processing that vary across centers.
Huang et al. [26] applied U-Net with minor modifications
for head and neck cancer gross tumor volume segmenta-
tion on PET/CT images. Results were obtained for a dataset
of 22 patients using manual segmentation as a surrogate of
truth. Blanc-Durand et al. [3] evaluated U-Net for glioma
segmentation on PET images with the fluoroethyl-tyrosine
(FET) tracer. Their dataset contained only 37 patients with
manually segmented lesions. Leung et al. [33] used a modi-
fied U-Net trained on simulated PET images and fine-tuned
using a clinical dataset of 160 patients with manual delin-
eations for lung cancer segmentation. In cervical cancer,
Chen et al. [5] proposed to combine a 2D CNN and a
post-processing step that relies on prior anatomical infor-
mation on the tumor roundness and its position relative
to the bladder. The choice of the 2D network was dic-
tated by the limited size of the available dataset that con-
tained 1176 slices from 50 patients, and the surrogate of
truth was also obtained through manual delineation. Within
the scope of the recent MICCAI challenge on automatic
PET tumor functional volume delineation, the CNN-based
method reached the highest score compared to twelve other
approaches, among them some of the current state of the art
[22].
In this paper, we focused our experiments on cervical
cancer. Approximately 570,000 cases of cervical cancer
and 311,000 deaths from the disease occurred in 2018 and
this type of cancer was the fourth most common cancer
in women worldwide [1]. Recently, predictive models rely-
ing on textural features from tumor volumes in PET images
were able to identify the subset of patients that will suf-
fer from recurrence after treatment with clinically relevant
accuracy [37, 46]. This obviously requires accurate delin-
eation of the tumor volume in the PET images and this is
achieved without the use of the associated CT image. Due to
the anatomical proximity between the cervix and the blad-
der that generally has similar FDG uptake in PET scans,
conventional techniques (e.g., thresholding, region- and
boundary-based methods) provide poor results if applied
to the whole image without additional prior knowledge
or constraints, which is why a VOI excluding physiolog-
ical uptake usually needs to be provided as input to the
method. For instance, the use of FLAB, as described in
the radiomic study above [37], requires an expert to first
manually define a VOI containing the tumor but exclud-
ing the bladder, in which FLAB is then applied to delineate
the tumor. However, this step can be quite labor-intensive
and time-consuming, especially when the tumor uptake and
bladder are very close to each other, hindering the potential
clinical translation of these segmentation tools, and in turn
the use of the predictive radiomics-based models. A fully
automated segmentation step, without the manual deter-
mination of the VOI, is therefore highly desirable in that
context.
The purpose of our study was thus to propose a U-
Net-based model for the fully automated delineation (i.e.,
without the need for visual detection of their location and
manual determination of a VOI) of 3D functional primary
tumor volumes in PET images only, especially in the
specific context of cervical cancer where the pathological
uptake of interest is located close to a physiological one
that should not be included (here, the bladder). A secondary
objective was to train the network on a reliable ground
truth obtained through accurate and robust PET semi-
automated segmentation instead of manual delineation. A
final objective was to train and evaluate the performance
of our model under standard clinical imaging conditions,
considering a multi-center patient cohort without any
prior standardization in the data acquisition or image
reconstruction processes.
Materials andmethods
PET images and training relying on FLAB-derived
ground truth
Our first objective is to achieve fully automated determina-
tion of the functional uptake boundaries in PET images only,
without relying on assumptions regarding its correspon-
dence with anatomical boundaries and to avoid registration
issues, which are important in the case of cervical cancer
due to the elastic nature of organs in this body region. We
decided to train and evaluate the proposed model exclu-
sively on real clinical images, contrary to recent recom-
mendations by the task group 211 of the AAPM (American
Association of Physicists in Medicine) dedicated on PET
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Fig. 1 Proposed Encoder-Decoder Network with residual blocks. The number of output channels is depicted under blocks of each group
auto-segmentation, which advises to rely on a combination
of simulated, phantom, and clinical images [20]. Indeed,
usually the number of clinical images available for train-
ing and validation is small, and the surrogate of truth is
questionable when only manual delineations from experts
are available. In such a context, results obtained on large
datasets of simulated and/or phantom images can indeed
increase the confidence in the results obtained in a smaller
amount of clinical cases with less reliable surrogate of truth.
However, in the present work, we exploited a large dataset
of images that were processed by experts using a semi-
automated approach (see section below detailing how the
ground truth was generated) for the purpose of radiomics-
based outcome modeling studies. In addition, one objective
of this work is to evaluate the ability of the proposed
approach to deal with fully automated tumor uptake delin-
eation when it is located close to a physiological one that
should not be included. Simulated or phantom images cor-
responding to this specific context are currently not avail-
able in large amounts to train and evaluate a CNN-based
approach.
We collected a dataset of 232 FDG PET images
of patients from five institutions, all with histologically
proven cervical cancer, with clinical stage IB1-IVB1
(see Supplementary Fig. 1). All images contained the
abdominopelvic cavity and were acquired for diagnostic
and staging purposes before chemoradiotherapy followed
1According to the staging system of the International Federation of
Gynecology and Obstetrics (FIGO).
by brachytherapy. Collected images considerably differed
in acquisition protocols (scanning duration per bed position,
injected radiopharmaceutical dose) and reconstruction
(algorithms, use of time of flight information, resolution
modeling, voxel and matrix sizes) (see Table 1). Data
were corrected for randoms and scatter in all cases. All
reconstructed images were corrected for attenuation using
the associated low-dose CT.
An objective of our work is to train the network
using a reliable ground truth excluding the bladder uptake.
Segmentation of the tumor volumes to generate the ground
truth was performed on PET images using the FLAB
algorithm [16] applied in a semi-automated manner: first, a
VOI containing the tumor uptake and excluding the nearby
bladder and other physiological uptakes was manually
defined by the user. The FLAB algorithm was then run
within that VOI to generate a segmentation mask that
was reviewed by the user. If this mask was deemed
unsatisfactory, the user had the option to re-run the
algorithm after specifying different values of initialization
parameters in order to obtain a more satisfying result.
Finally, the results for all tumors were reviewed and in
some cases (<5%) manually edited before being validated
by two experts with more than 15 years of clinical practice.
Given that FLAB in such a context has been demonstrated
to provide accurate and reliable results in numerous studies
[11, 21, 49], including for complex heterogeneous cases [17,
19] and over different scanner model and reconstruction
algorithms, especially compared to manual delineation
[18], we consider this ground truth sufficiently reliable
for the purpose of training and evaluating the proposed
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Table 1 Summary of patients, including the different characteristics of the scanners, and associated reconstruction methods and parameters
Institution Number
of patients




































24 Philips Gemini TF 4 × 4 × 4 BLOB-OS-TF 109 ± 21 228 ± 50
University Hospital
of Liège, Belgium
90 Philips Gemini TF 4 × 4 × 4 BLOB-OS-TF 73 ± 16 260 ± 32
approach. Although FLAB was applied only within the
manually determined VOI, we then registered the obtained
segmentation mask onto the entire PET image used as input
to the network for training and testing.
Network architecture
The widely used 3D U-Net model [4] served as the basis
for our network design. Although not the main objective
of the present work, we nonetheless introduced three
optimizations beyond the standard U-Net model:
1. Original U-Net consists of conventional convolutional
blocks composed of a 3 × 3 × 3 convolution, a
normalization layer (e.g., batch norm), and a ReLU
activation function as a basic element of the network.
We chose to rely upon a residual block with full pre-
activation [24] supplemented by a concurrent spatial
and channel squeeze and excitation (scSE) module
(Fig. 1, gray blocks).
2. An important part of the proposed architecture is the
integration of squeeze and excitation (SE) blocks that
aim at providing the option to compute weights for
the feature maps, so the network can put more or less
attention on some of them. We implemented SE blocks
within the full pre-activation residual blocks, namely
a specific modification called concurrent spatial SE
(scSE) that has been shown to perform better for image
segmentation tasks [48]. In order to include the scSE
module in the residual block, we followed the same
approach that was applied in SE-ResNet architectures
[25]. Due to the high memory consumption working
with 3D images, we switched from using batch norm
layers to instance normalization (instance norm) that
was shown to work better in a small-batch regime [50].
3. We replaced max pooling operations in the encoder
of the network by learnable downsampling blocks
(Fig. 1, red blocks), which consist of one 3 × 3 ×
3 strided convolutional layer, the instance norm, the
ReLU activation, and the scSE module. Similarly, we
implemented upsampling blocks in the decoder of the
network using a 3 × 3 × 3 transposed convolution
instead (Fig. 1, green blocks). To reduce memory
consumption and increase the receptive field of the
network, we implemented the first downsampling block
with a kernel size of 7 × 7 × 7 right after the input.
The last convolutional layer followed by the sigmoid
activation function to produce the model output was
applied with a kernel size of 1 × 1 × 1.
Experimental settings
Data preprocessing
The PET images exhibited a large variability of voxel sizes
(see Table 1) that can adversely affect the model perfor-
mance since CNNs cannot natively interpret spatial dimen-
sions with different scales. Therefore, we first interpolated
all PET images and corresponding segmentation masks to a
common resolution of 4×4×2mm3 through the use of linear
interpolation. A slice thickness of 2 mmwas chosen to retain
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small image details that could be lost if interpolated at a
larger voxel size. Linear interpolation was chosen after com-
parison with other techniques including Nearest Neighbor
and B-spline, which led to decreased performance.
PET image intensities can exhibit a high variability in
both within image and between images. In order to reduce
these variabilities and use them as the input for the CNNs,
we applied Z-score normalization for each scan separately,
with the mean and the standard deviation computed based
only on voxels with non-zero intensities corresponding to
the body region.
Data augmentation
Due to the large variability in shapes, sizes, and heterogene-
ity of tumor uptakes in PET images, data augmentation can
play a useful role in model training. To aid the model learn
features invariant to affine transformations that are realistic,
we applied mirroring on the axial plane, rotations in ran-
dom directions with the angle uniformly sampled from the
range [5, 15] degrees along the random set of axes, and scal-
ing with a random factor between 0.8 and 1.2. In order to
increase the diversity in lesion shapes, we relied on elas-
tic deformations. Gamma correction with γ sampled from
the uniform distribution between 0.8 and 1.2, and contrast
stretching between 0 and 0.8–1.2 of the original range of
values was applied to adjust voxel intensity distributions. To
improve model robustness, we also added Gaussian noise to
training samples. The standard deviation of the noise was
equal to 0.1–0.2 standard deviations of the training sam-
ple. All augmentation methods were applied independently
during model training with a probability of 0.2.
Training procedure
Due to the large size of PET images, we trained the model
on randomly extracted patches of 128 × 128 × 64 voxels
with a batch size of 2. Since all PET images corresponded
to the abdominopelvic cavity with a number of axial slices
ranging from 77 to 192, the chosen patch size was large
enough to cover a significant part of the input PET image
for all patients.
We trained the model for 400 epochs using Adam
optimizer with β1 = 0.9 and β2 = 0.99 for exponential
decay rates for moment estimates. We applied a cosine
annealing schedule [36], gradually reducing the learning
rate from lrmax = 10−4 to lrmin = 10−6 for every 25
epochs and performing the adjustment at each epoch.
Considering the fact that the Dice similarity coefficient
(DSC) is one of the most common metrics used for the
evaluation in medical image segmentation, we trained the
model with the Soft Dice Loss. Based on [40], in case
of binary segmentation, the loss function for one training
example can be written as
L(y, ŷ) = 1 − 2
∑N










where yi ∈ {0, 1} is the the binary label for the i-th
voxel; ŷi ∈ [0, 1] predicted probability for the i-th voxel.
Additionally, we applied Laplacian smoothing by adding +1
to the numerator and the denominator in the loss function
to avoid the zero division in cases when only one class is
represented in the training example.
Multi-center cross-validation
Cross-validation is probably the simplest and most widely
used method for estimating the expected prediction error of
a model on an independent test sample [15]. Importantly,
cross-validation is based on the assumption that data
samples in the train and test folds are drawn from
the same distribution. However, as already mentioned in
section “Network architecture,” no standardization in the
acquisition or reconstruction protocols were implemented
across the five institutions in which the images were
collected. In addition, different PET/CT imaging devices
with variable overall performance were used in these
centers. Therefore, in order to obtain a more reliable
estimate of the model performance, we implemented 5-fold
cross-validation where each fold was composed only of
samples from one of the 5 centers. This simulated a “real-
life scenario” in which data from one or several centers are
used for training and evaluating a model that is then used
in yet another center. For each cross-validation split of the
data, we randomly set aside 20% of training samples to
tune hyperparameters of the model and to assess the model
performance during training.
Evaluationmetrics
Aside from the DSC metric quantifying global volume
overlap, we used precision (a.k.a. positive predictive value)
P and recall R (a.k.a. sensitivity) to further evaluate model
performance, as recommended by the TG211 [20], where
DSC can be written as the harmonic mean of precision and
recall:
DSC = 2 P · R
P + R (2)
Using these metrics, we compared our proposed network
to the standard U-Net (StdU-Net) as a baseline model.
In addition, a comparison was made with the use of a
fixed thresholding method (based on 40% of the maximum
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Table 2 Segmentation results obtained on the different test folds with the use of cross-validation
Metrics Model Test fold Average
Brest (n=69) Nantes (n=23) Montreal (n=26) Barcelona (n=24) Liège (n=90)
DSC T 40 0.33 ± 0.36 0.57 ± 0.41 0.37 ± 0.31 0.22 ± 0.24 0.18 ± 0.22 0.33 ± 0.15
StdU-Net 0.68 ± 0.20 0.79 ± 0.12 0.77 ± 0.13 0.83 ± 0.10 0.79 ± 0.13 0.77 ± 0.05
Proposed 0.77 ± 0.15 0.81 ± 0.13 0.77 ± 0.21 0.84 ± 0.11 0.79 ± 0.13 0.80 ± 0.03
Precision T 40 0.30 ± 0.37 0.56 ± 0.43 0.29 ± 0.28 0.18 ± 0.21 0.14 ± 0.21 0.30 ± 0.16
StdU-Net 0.61 ± 0.24 0.75 ± 0.15 0.74 ± 0.16 0.81 ± 0.17 0.79 ± 0.18 0.74 ± 0.08
Proposed 0.69 ± 0.20 0.73 ± 0.16 0.77 ± 0.22 0.81 ± 0.18 0.77 ± 0.19 0.75 ± 0.05
Recall T 40 0.48 ± 0.43 0.74 ± 0.35 0.65 ± 0.40 0.38 ± 0.36 0.38 ± 0.37 0.52 ± 0.17
StdU-Net 0.88 ± 0.15 0.87 ± 0.10 0.85 ± 0.15 0.90 ± 0.09 0.84 ± 0.14 0.87 ± 0.02
Proposed 0.93 ± 0.10 0.96 ± 0.04 0.83 ± 0.19 0.91 ± 0.08 0.87 ± 0.14 0.90 ± 0.05
The proposed model was compared to the standard U-Net model and the fixed thresholding method in terms of DSC, precision and recall. The
mean and standard deviation of each metric on the test folds are computed across corresponding data samples. Average results are reported across
the test folds
standardized uptake within the tumor, denoted from here
onwards as T40), still widely used in the literature despite
its obvious limitations [20, 22].
Results and discussion
The results of all methods are summarized in Table 2
and Supplementary Table 1. As expected, T40 obtained
poor performance across all test folds compared to stdU-
Net and the proposed model. On average, our proposed
model outperformed its StdU-Net counterpart in terms of
DSC (0.80 vs. 0.77), with a slighlty smaller spread (0.03
vs. 0.05). The largest difference between the proposed
method and its standard counterpart was measured on the
“Brest” test fold, where StdU-Net demonstrated relatively
poorer performance (0.77 vs. 0.68). However, on the
other test folds, both models achieved closer results. The
superiority of the proposed model was due to a better
recall (0.90 vs. 0.87), whereas the difference in terms of
precision was smaller (0.75 vs. 0.74). Kolmogorov-Smirnov
and Wilcoxon signed-rank tests both indicated that the
difference in predictions of two models was significant (α =
0.05) only for all evaluation metrics on the Brest test fold,
and for recall on “Nantes” (see Supplementary Table 1).
This finding is in line with previous observations
that, when properly tuned, the standard U-Net model
can provide highly competitive results in many image
segmentation tasks, especially in medical imaging. For
example, top-ranked results were obtained in recent
segmentation challenges using the ordinary U-Net model
[28–30]. Under these circumstances, each step in the entire
pipeline (data preprocessing, data augmentation, training
procedure, etc.) may have a much larger impact on the
model performance than a careful or complex re-design of
the model architecture. For instance, we observed in our
experiments that applying b-spline interpolation for image
resampling instead of linear interpolation deteriorated both
models’ performance by an average of nearly 8.5% on the
test folds.
Both models achieved higher recall (between 0.83 and
0.93 on average) than precision (between 0.61 and 0.81)
in all test folds, showing a trend in overestimating the
ground truth rather than underestimating it. One of the
most challenging aspects pertaining to cervical cancer
segmentation in PET images is to distinguish the tumor
uptake from the adjacent bladder uptake. In all cases,
even when the tumor was very close to the tumor, the
proposed approach was capable of address this problem
independently of the size, location, and shape of the tumor
uptake (see examples in Fig. 3). However, the wider spread
of results on the two largest test folds (Brest, Liège) (see
Fig. 2) could mean that the applied data augmentation
techniques are not able to completely mimic all possible
variations in presented PET images and alternatives should
be investigated, such as, for example, relying on realistic
simulated PET images to add more data for training. In
addition, due to our 5-fold evaluation scheme based on
clinical centers, the size of training sets (and as a result
the variety of encountered examples) varied substantially
(e.g., holding out Liege yields 146 training cases whereas
holding out Nantes yields 209), which could also contribute
in explaining these differences (Fig. 3).
Analyzing predictions of the models, we identified a
number of outliers2 in each test fold (see examples in
Fig. 4). When considering the DSC metric, the total number
of outliers in the entire dataset was equal to 15 (12 for
2A data point xi from a dataset X = {x1, . . . , xn} is an outlier, if
xi < q1 + 1.5(q3 − q1), where qi is the i-th empirical quartile of X.
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(a) DSC (b) Precision (c) Recall
Fig. 2 Box plots of the results on the test folds
StdU-Net) and varies from 2 to 4 across the test folds.
In most cases, the model failed to accurately segment
images with relatively small tumor regions (see Fig. 4a, d).
More specifically, 11 outliers corresponded to cases where
the tumor size was less than 200 voxels (i.e., 6.4 cm3),
whereas the average value across the dataset was 1160
voxels (i.e., 37.12 cm3). The other source of errors in the
model predictions is the presence of surrounding tissues
with a relatively high uptake that can be misclassified as the
tumor (see Fig. 4b, c, e).
The performance was affected by tumor volume (see
Supplementary Table 2 and Supplementary Fig. 2): the
lowest results were obtained in the first decile group3 with
DSC = 0.56 compared to the performance obtained on
larger tumor volumes (significantly higher between 0.71
and 0.85). This happened due to precision that was steeply
increasing along with the tumor size (0.44 to 0.90), whereas
recall remained relatively stable (between 0.81 and 0.94).
Examining the impact of the tumor contrast4, we found
that the proposed model demonstrated the worst results
on low contrast images (see Supplementary Table 3 and
Supplementary Fig. 3). The decile group with the lowest
tumor contrast had DSC = 0.67 and recall = 0.77,
which were significantly different from the results on
other groups (0.77 to 0.84, and 0.88 to 0.93, respectively).
Investigating the relation between FIGO stages and the
model performance, we did not find significant differences
with DSC ranging from 0.75 to 0.82 (see Supplementary
Table 4 and Supplementary Fig. 4).
It should be emphasized that although we used a
previously well-validated approach to define the ground-
truth, this remains a surrogate of truth. In the absence of
3The first decile group corresponds to 10% of patients with the
smallest tumors.
4We roughly estimated tumor contrast as the ratio between average
tumor intensity and average intensity of the body region.
perfectly registered histopathological spatial information,
this is the best we can achieve with a single segmentation
method, which obviously provides imperfect results in a
small number of cases (for instance highly heterogeneous
or very small and low contrast cases) [22]. An even
better approach would consist in generating several manual
delineations by experts (at least three) in addition to
the results of FLAB (other algorithms with proven good
performance [22] could be added too) and generating a
statistical consensus of all these segmentation results. This
would provide the proposed model an even more reliable
ground truth to learn from, but it would be considerably
more time-consuming and tedious, especially for generating
the numerous manual delineations. Alternatively, our
approach consisting in training the network on rigorously
determined ground-truth masks could be reproduced by
relying on other semi-automated methods with similar
demonstrated levels of performance [20, 22]. Once trained,
the proposed network can be applied to new data
instantaneously, without the need for user intervention
beyond checking and validating the output result.
Unlike [5], we did not rely on any post-processing
techniques built on prior anatomical information. First,
based on the segmentation results of the proposed model, it
appears able to natively learn the anatomic position of the
tumor relative to the bladder from training samples without
additional a priori guidance. Second, the assumption about
the tumor roundness contradicts numerous examples in our
dataset, especially those with heterogeneous distributions
(see Fig. 3b, e). Although in the present case we focused
on PET-only delineation, the proposed model can be
trained using multiple different modalities as input. It
might be beneficial in specific cases, such as dealing
with small and/or low-contrast tumors, to extract additional
information from associated CT or MRI modalities. For
instance, in the context of the MICCAI 2020 Head and
Neck Tumor segmentation challenge (HECKTOR), we











Fig. 3 Examples of the model predictions in each test fold. Axial slices. (first row) Input images, (second row) input images with ground truth












Fig. 4 Examples of outliers in each test fold. Axial slices. (first row) Input images, (second row) input images with ground truth segmentation,
(last row) input images with predicted segmentation. Evaluation metrics for whole scans are provided in format (DSC, precision, recall)
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applied a similar U-Net-based model to delineate lesions in
combined PET/CT images, reaching 1st rank performance
with DSC of 0.76 [27]. However, the main challenge in
that case is to have a reliable ground truth determined on
fused multimodal data, which could prove quite difficult
in the cervical region due to anatomical deformations and
differences between PET and CT datasets.5
With respect to our original objectives, our results
obtained with the use of multi-center cross-validation
allow concluding that the designed model is able to
provide similar performance on PET images from different
institutions and is robust to variations in scanner types,
reconstruction algorithms, and post-processing methods.
In addition, it allows for fully automated delineation of
the tumor uptake without the need to exclude the bladder
uptake, either manually or through the incorporation of
additional prior information or constraints.
Conclusion
In this work, we trained a modified U-Net model for
fully automatic tumor uptake delineation in PET images
in a multi-center context, without the need for additional
anatomical information or prior constraints. The ability of
the proposed model to learn and perform well for this
task was demonstrated in PET images of 232 patients
collected from five institutions. The ground-truth labels
for all patients were generated by experts with the use
of a semi-automated algorithm, to reduce observer-related
variability and to avoid relying on manual delineations.
We presented a versatile pipeline that includes appropriate
data preprocessing and augmentation, design of the model
architecture beyond the standard U-Net model, and an
optimized training procedure. We mimicked a typical
clinical scenario and conducted all experiments in a multi-
center context. The designed model obtained good average
accuracy for all considered institutions with very small
standard deviation (DSC of 0.80 ± 0.03) without requiring
any change in the pipeline. It slightly improved accuracy
over the standard U-Net model, although both approaches
provided good results and largely outperformed the fixed
threshold approach. The described approach managed
to avoid including the bladder uptake in the resulting
segmentation without the need for additional anatomical
information (for instance using the CT image) or priors
such as shape constraints, and can therefore achieve fully
automated delineation of the tumor uptake without the
need for any user intervention. It can be implemented
with minimal modifications to solve a variety of other
5In the HECKTOR challenge, manual delineation performed by a
single expert was used as the ground truth.
segmentation tasks in different medical imaging modalities
and could facilitate the deployment of fully automated
radiomics pipelines.
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